Voyager Therapeutics presents at Citi Biopharma Conference; no specific updates disclosed in filing excerpt

Voyager Therapeutics, Inc.

Company presented at Citi's 2025 Biopharma Back to School Conference on September 2, 2025.
Presentation titled 'Leveraging Genetics to Treat Neurological Diseases' focuses on genetic approaches.
No financial results, pipeline milestones, or guidance changes are identifiable from the provided excerpt.
The filing does not contain material new information beyond the fact of the presentation.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.